Bernard Le Foll

Bernard Le Foll's AcademicInfluence.com Rankings

Bernard Le Foll

Philosophy

#8584

World Rank

#11994

Historical Rank

Logic

#5617

World Rank

#7028

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Bernard Le Foll's Degrees

Doctorate Medicine Université Paris Cité

Why Is Bernard Le Foll Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Bernard Le Foll's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies (2013) (418)
Genetics of dopamine receptors and drug addiction: a comprehensive review (2009) (369)
The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. (2006) (330)
Dopamine D3 Receptors Expressed by All Mesencephalic Dopamine Neurons (2000) (323)
Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence (2005) (288)
Prevalence and correlates of major depressive episode in pregnant and postpartum women in the United States. (2011) (243)
Nicotine induces conditioned place preferences over a large range of doses in rats (2005) (224)
Identification of Dopamine D1–D3 Receptor Heteromers (2008) (203)
Psychosocial interventions for cannabis use disorder. (2016) (192)
A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning (2005) (188)
The dopamine D3 receptor and drug dependence: Effects on reward or beyond? (2005) (183)
Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences (2004) (182)
Effects of nicotine in experimental animals and humans: an update on addictive properties. (2009) (182)
Role of the dopamine D3 receptor in reactivity to cocaine‐associated cues in mice (2002) (178)
Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis (2017) (174)
The future of endocannabinoid-oriented clinical research after CB1 antagonists (2009) (167)
The dopamine D3 receptor, a quarter century later (2017) (165)
Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations (2017) (150)
Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats (2003) (148)
The potential role of dopamine D3 receptor neurotransmission in cognition (2013) (147)
Granular Insular Cortex Inactivation as a Novel Therapeutic Strategy for Nicotine Addiction (2010) (143)
Inhibition of Anandamide Hydrolysis by Cyclohexyl Carbamic Acid 3′-Carbamoyl-3-yl Ester (URB597) Reverses Abuse-Related Behavioral and Neurochemical Effects of Nicotine in Rats (2008) (139)
A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study (2018) (135)
Nicotine as a typical drug of abuse in experimental animals and humans (2006) (129)
Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations. (2017) (114)
Blockade of Nicotine Reward and Reinstatement by Activation of Alpha-Type Peroxisome Proliferator-Activated Receptors (2011) (114)
Child Marriage in the United States and Its Association With Mental Health in Women (2011) (109)
Cannabis use and cannabis use disorders among individuals with mental illness. (2013) (109)
Dopamine D3 Receptor Ligands Block Nicotine-Induced Conditioned Place Preferences through a Mechanism that does not Involve Discriminative-Stimulus or Antidepressant-Like Effects (2005) (103)
Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre‐clinical and clinical studies (2008) (103)
Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions. (2012) (99)
The effect of post-traumatic stress disorder on the risk of developing prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions III. (2017) (94)
Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans. (2005) (93)
Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol (2015) (92)
Obesity and cannabis use: results from 2 representative national surveys. (2011) (91)
Dopamine D3 receptor agents as potential new medications for drug addiction (2000) (91)
Pharmacotherapies for cannabis dependence. (2019) (91)
Bipolar disorder and co-occurring cannabis use disorders: Characteristics, co-morbidities and clinical correlates (2013) (87)
Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking (2012) (86)
Treatment of tobacco dependence: integrating recent progress into practice (2007) (84)
Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: results from a large representative sample. (2013) (83)
Disruption of nicotine conditioning by dopamine D3 receptor ligands (2003) (81)
The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking. (2010) (81)
Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration—comparison with CB1 receptor blockade (2009) (80)
Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial (2018) (80)
High Reinforcing Efficacy of Nicotine in Non-Human Primates (2007) (74)
Phasic D1 and tonic D2 dopamine receptor signaling double dissociate the motivational effects of acute nicotine and chronic nicotine withdrawal (2012) (70)
Cannabis use and cannabis use disorder (2021) (69)
How generalisable to community samples are clinical trial results for treatment of nicotine dependence: a comparison of common eligibility criteria with respondents of a large representative general population survey (2011) (68)
Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings. (2019) (67)
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine‐induced dopamine elevations in the nucleus accumbens shell in rats (2012) (66)
Electrical Stimulation of the Insular Region Attenuates Nicotine-Taking and Nicotine-Seeking Behaviors (2013) (65)
Effects of a Selective Cannabinoid CB2 Agonist and Antagonist on Intravenous Nicotine Self Administration and Reinstatement of Nicotine Seeking (2012) (65)
The endocannabinoid system as a target for addiction treatment: Trials and tribulations (2017) (64)
Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used. (2012) (63)
Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings. (2016) (63)
Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice. (2005) (63)
Smoking cessation guidelines: evidence-based recommendations of the French Health Products Safety Agency (2005) (63)
Gender and stimulus difference in cue-induced responses in abstinent heroin users (2007) (61)
Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia (2010) (60)
Noradrenergic α1 Receptors as a Novel Target for the Treatment of Nicotine Addiction (2010) (60)
Blockade of Dopamine D4 Receptors Attenuates Reinstatement of Extinguished Nicotine-Seeking Behavior in Rats (2012) (59)
Dopamine D3 Receptor Is Necessary for Ethanol Consumption: An Approach with Buspirone (2014) (59)
Obesity and Cannabis Use: Results From 2 Representative National Surveys (2011) (59)
The Insula: A Brain Stimulation Target for the Treatment of Addiction (2019) (58)
Proceedings from the 9th annual conference on the science of dissemination and implementation (2017) (57)
Polydrug use disorders in individuals with opioid use disorder. (2019) (57)
Exploring the association between lifetime prevalence of mental illness and transition from substance use to substance use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC). (2013) (56)
Peroxisome proliferator-activated receptor (PPAR) agonists as promising new medications for drug addiction: preclinical evidence. (2013) (55)
The Fatty Acid Amide Hydrolase C385A Variant Affects Brain Binding of the Positron Emission Tomography Tracer [11C]CURB (2015) (54)
The selective anandamide transport inhibitor VDM11 attenuates reinstatement of nicotine seeking behaviour, but does not affect nicotine intake (2011) (54)
Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adults (2019) (53)
The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability (2016) (53)
Elevation of Dopamine Induced by Cigarette Smoking: Novel Insights from a [11C]-(+)-PHNO PET Study in Humans (2014) (52)
Dopamine D3 Receptors in the Basolateral Amygdala and the Lateral Habenula Modulate Cue-Induced Reinstatement of Nicotine Seeking (2014) (52)
Role of the Endogenous Cannabinoid System in Nicotine Addiction: Novel Insights (2015) (51)
Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings. (2014) (51)
Noradrenergic α1 Receptors as a Novel Target for the Treatment of Nicotine Addiction (2010) (50)
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys (2016) (49)
Nicotine pre-exposure does not potentiate the locomotor or rewarding effects of Δ-9-tetrahydrocannabinol in rats (2006) (49)
Role of DRD3 in morphine-induced conditioned place preference using drd3-knockout mice (2004) (48)
A Selective Role for Dopamine D4 Receptors in Modulating Reward Expectancy in a Rodent Slot Machine Task (2014) (48)
Exposure to Nicotine Produces an Increase in Dopamine D2High Receptors: A Possible Mechanism for Dopamine Hypersensitivity (2010) (47)
Time-Dependent Neuroendocrine Alterations and Drug Craving during the First Month of Abstinence in Heroin Addicts (2009) (47)
Dopamine D4 receptors in psychostimulant addiction. (2014) (46)
Conditioned Place Preference Induced by Licit Drugs: Establishment, Extinction, and Reinstatement (2008) (46)
The dopamine D3 receptor and drug addiction (2001) (45)
Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline (2019) (45)
Pharmacotherapies for cannabis dependence. (2014) (44)
Impact of age at onset of cannabis use on cannabis dependence and driving under the influence in the United States. (2015) (44)
Brain-derived neurotrophic factor and the plasticity of the mesolimbic dopamine pathway. (2004) (42)
Cannabis and Δ9-tetrahydrocannabinol (THC) for weight loss? (2013) (42)
Association of a polymorphism in the NRXN3 gene with the degree of smoking in schizophrenia: A preliminary study (2009) (42)
Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB (2016) (41)
Circadian alteration in neurobiology during protracted opiate withdrawal in rats (2010) (41)
IDENTIFICATION OF DOPAMINE D 1 -D 3 RECEPTOR HETEROMERS: INDICATIONS FOR A ROLE OF SYNERGISTIC D 1 -D 3 RECEPTOR INTERACTIONS IN THE STRIATUM* (2008) (40)
Effects of baclofen on conditioned rewarding and discriminative stimulus effects of nicotine in rats (2008) (40)
Major depression and suicide attempts in patients with liver disease in the United States (2015) (39)
Dopamine D3 receptor ligands for the treatment of tobacco dependence (2007) (39)
Involvement of the rostral agranular insular cortex in nicotine self-administration in rats (2015) (38)
The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda. (2020) (38)
Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development (2014) (37)
The endocannabinoid system: a new molecular target for the treatment of tobacco addiction. (2008) (36)
Acute and residual effects of smoked cannabis: Impact on driving speed and lateral control, heart rate, and self-reported drug effects. (2019) (35)
Effects of chronic caffeine exposure on adenosinergic modulation of the discriminative-stimulus effects of nicotine, methamphetamine, and cocaine in rats (2009) (34)
Subtype (2020) (32)
Deep TMS of the insula using the H-coil modulates dopamine release: a crossover [11C] PHNO-PET pilot trial in healthy humans (2018) (32)
AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking (2013) (32)
Cannabis use and mental health-related quality of life among individuals with anxiety disorders. (2012) (31)
Differential Involvement of the Agranular vs Granular Insular Cortex in the Acquisition and Performance of Choice Behavior in a Rodent Gambling Task (2015) (31)
The Impact of Selective Dopamine D2, D3 and D4 Ligands on the Rat Gambling Task (2015) (30)
Baseline Expression of α4β2* Nicotinic Acetylcholine Receptors Predicts Motivation to Self-administer Nicotine (2009) (30)
Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series (2016) (28)
Dopamine D3 receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam (2011) (27)
Neuronal calcium sensor-1 deletion in the mouse decreases motivation and dopamine release in the nucleus accumbens (2016) (27)
Involvement of the caudal granular insular cortex in alcohol self-administration in rats (2015) (27)
Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies (2018) (26)
Differential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on nicotine versus cocaine self-administration and relapse in squirrel monkeys (2016) (26)
Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats (2016) (25)
Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans (2016) (25)
Ethanol does not affect discriminative-stimulus effects of nicotine in rats. (2005) (24)
Cannabis Legalization and Acute Harm From High Potency Cannabis Products: A Narrative Review and Recommendations for Public Health (2020) (22)
Psychiatric Disorder (2020) (22)
Psychosocial and pharmacological interventions for the treatment of cannabis use disorder (2018) (22)
Pharmacotherapy of Alcohol Use Disorders and Concurrent Psychiatric Disorders: A Review (2012) (22)
Analysis of treatment-resistant schizophrenia and 384 markers from candidate genes (2012) (22)
Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs (2020) (22)
Neuronal circuitry underlying the impact of D3 receptor ligands in drug addiction (2015) (21)
Perioperative Pain and Addiction Interdisciplinary Network (PAIN): consensus recommendations for perioperative management of cannabis and cannabinoid-based medicine users by a modified Delphi process. (2020) (21)
Therapeutic Potential of Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Substance Use Disorders: A Synthesis of Preclinical and Human Evidence (2020) (20)
Replicated association of the NR4A3 gene with smoking behaviour in schizophrenia and in bipolar disorder (2010) (20)
Transcriptomic Characterization of the Human Habenula Highlights Drug Metabolism and the Neuroimmune System (2018) (20)
Consensus‐based recommendations for titrating cannabinoids and tapering opioids for chronic pain control (2020) (20)
Varenicline-Induced Elevation of Dopamine in Smokers: A Preliminary [11C]-(+)-PHNO PET Study (2016) (19)
Inhibition of monoacylglycerol lipase (MAGL) enhances cue-induced reinstatement of nicotine-seeking behavior in mice (2016) (19)
A review of positron emission tomography studies exploring the dopaminergic system in substance use with a focus on tobacco as a co-variate (2017) (19)
The agranular and granular insula differentially contribute to gambling-like behavior on a rat slot machine task: effects of inactivation and local infusion of a dopamine D4 agonist on reward expectancy (2016) (18)
Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURB (2020) (18)
Translational strategies for therapeutic development in nicotine addiction: Rethinking the conventional bench to bedside approach (2014) (17)
Management of mood and anxiety disorders in patients receiving opioid agonist therapy: Review and meta‐analysis (2017) (17)
Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response (2010) (17)
Effects of various cannabinoid ligands on choice behaviour in a rat model of gambling (2016) (17)
Association study of BDNF and DRD3 genes in schizophrenia diagnosis using matched case–control and family based study designs (2010) (17)
Effects of cannabidiol on alcohol-related outcomes: A review of preclinical and human research. (2019) (17)
The complexity of pharmacology of cannabidiol (CBD) and its implications in the treatment of brain disorders (2019) (16)
Impact of Substance Use Disorder Pharmacotherapy on Executive Function: A Narrative Review (2019) (16)
Analysis of CpG SNPs in 34 genes: Association test with suicide attempt in schizophrenia (2013) (16)
Alcohol Intoxication by Binge Drinking Impairs Neuroplasticity (2016) (16)
Investigation of the genetic interaction between BDNF and DRD3 genes in suicidical behaviour in psychiatric disorders (2015) (16)
Clonidine attenuates morphine withdrawal and subsequent drug sensitization in rhesus monkeys (2007) (16)
Acute and residual mood and cognitive performance of young adults following smoked cannabis (2020) (15)
Multiple variants of the DRD3, but not BDNF gene, influence age-at-onset of schizophrenia (2007) (15)
Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users : Imaging With the Novel Radiotracer [ 11 C ] CURB (2016) (14)
Tobacco and nicotine use (2022) (14)
Screening and Treatment for Alcohol, Tobacco and Opioid Use Disorders: A Survey of Family Physicians across Ontario (2015) (13)
The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale. (2018) (13)
Repurposing buspirone for drug addiction treatment. (2013) (13)
Effects of disulfiram on choice behavior in a rodent gambling task: association with catecholamine levels (2017) (13)
Thinking Beyond Legalization: The Case for Expanding Evidence-Based Options for Cannabis Use Disorder Treatment in Canada (2018) (13)
The effects of buspirone on occupancy of dopamine receptors and the rat gambling task (2017) (13)
Longitudinal alcohol consumption patterns and health‐related quality of life: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (2018) (13)
Substance dependence. (1998) (13)
Impairment of Neuroplasticity in the Dorsolateral Prefrontal Cortex by Alcohol (2017) (13)
Association of the orphan nuclear receptor NR4A1 with tardive dyskinesia (2010) (13)
Effect of a D3 receptor antagonist on context-induced reinstatement of nicotine seeking (2016) (13)
Topiramate does not alter nicotine or cocaine discrimination in rats (2008) (13)
Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic Disorders (2018) (12)
“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada (2022) (12)
Corticotropin-releasing hormone and dopamine release in healthy individuals (2017) (12)
D3 dopamine receptors and a missense mutation of fatty acid amide hydrolase linked in mouse and men: implication for addiction (2019) (12)
Cannabinoids: Friend or foe? (2015) (12)
Occupancy of dopamine D2 and D3 receptors by a novel D3 partial agonist BP1.4979: a [11C]-(+)-PHNO PET study in humans (2018) (12)
Exploring occupancy of the histamine H3 receptor by pitolisant in humans using PET (2020) (11)
Self-reported psychotic disorders among Individuals with substance use disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. (2012) (11)
Service delivery models for injectable opioid agonist treatment in Canada: 2 sequential environmental scans (2021) (11)
Inhibition of anandamide hydrolysis by URB597 reverses abuse-related behavioral and neurochemical effects of nicotine in rats (2009) (11)
Melatonin for Treatment-Seeking Alcohol Use Disorder patients with sleeping problems: A randomized clinical pilot trial (2020) (11)
Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial. (2022) (11)
Nicotine-taking and nicotine-seeking in C57Bl/6J mice without prior operant training or food restriction (2012) (11)
Presentation of Smoking-Associated Cues Does Not Elicit Dopamine Release after One-Hour Smoking Abstinence: A [11C]-(+)-PHNO PET Study (2013) (11)
Screening Medications for the Treatment of Cannabis Use Disorder. (2016) (11)
A method for co-creation of an evidence-based patient workbook to address alcohol use when quitting smoking in primary care: a case study (2018) (10)
Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies (2022) (10)
Extinction bursts in rats trained to self-administer nicotine or food in 1-h daily sessions. (2012) (10)
Alcohol Impairs N100 Response to Dorsolateral Prefrontal Cortex Stimulation (2018) (10)
Validation of an Extracerebral Reference Region Approach for the Quantification of Brain Nicotinic Acetylcholine Receptors in Squirrel Monkeys with PET and 2-18F-Fluoro-A-85380 (2007) (10)
Opioid-sparing effects of cannabinoids: Myth or reality? (2020) (10)
Outcomes of an integrated care pathway for concurrent major depressive and alcohol use disorders: a multisite prospective cohort study (2018) (10)
Association of the Fatty Acid Amide Hydrolase C385A Polymorphism with Alcohol Use Severity and Coping Motives in Heavy-drinking Youth. (2021) (9)
Brain Stimulation in Alcohol Use Disorders: Investigational and Therapeutic Tools. (2016) (9)
Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment (2018) (9)
Psychiatric disorders as vulnerability factors for nicotine addiction: what have we learned from animal models? (2015) (9)
Combining alcohol interventions with tobacco addictions treatment in primary care—the COMBAT study: a pragmatic cluster randomized trial (2017) (9)
When and How to Treat Possible Cannabis Use Disorder. (2018) (9)
Combined effect of alcohol and cannabis on simulated driving (2021) (9)
[Behavioral and cognitive therapy to break the smoking habit. Review of the literature]. (2002) (9)
Increased collision risk among drivers who report driving after using alcohol and after using cannabis (2014) (9)
Preliminary evaluation of a human laboratory model of impaired control over alcohol using intravenous alcohol self-administration (2018) (9)
Evaluating the Impact of Naltrexone on the Rat Gambling Task to Test Its Predictive Validity for Gambling Disorder. (2016) (8)
Safety and Efficacy of Varenicline for Smoking Cessation in Alcohol-Dependent Smokers in Concurrent Treatment for Alcohol Use Disorder: A Pilot, Randomized Placebo-Controlled Trial. (2020) (8)
Integrated care pathway for co‐occurring major depressive and alcohol use disorders: Outcomes of the first two years (2017) (8)
Reviewing pharmacogenetics to advance precision medicine for opioids. (2021) (8)
Testing the PPAR hypothesis of tobacco use disorder in humans: A randomized trial of the impact of gemfibrozil (a partial PPARα agonist) in smokers (2018) (8)
The effect of a clinical decision support system on prompting an intervention for risky alcohol use in a primary care smoking cessation program: a cluster randomized trial (2019) (8)
The effects of dopamine D4 receptor ligands on operant alcohol self-administration and cue- and stress-induced reinstatement in rats. (2019) (8)
A Preliminary Investigation of the Effect of Acute Alcohol on Dopamine Transmission as Assessed by [11C]‐(+)‐PHNO (2017) (7)
Influence of Nicotine Metabolism Ratio on [11C]-(+)-PHNO PET Binding in Tobacco Smokers (2018) (7)
Exploring the role of the Ser9Gly (rs6280) Dopamine D3 receptor polymorphism in nicotine reinforcement and cue-elicited craving (2020) (7)
Evaluating the Impact of Naltrexone on the Rat Gambling Task to Test Its Predictive Validity for Gambling Disorder (2016) (7)
Transcriptomic Characterization of the Human Insular Cortex and Claustrum (2019) (7)
892 – The Association Between Cannabis Use And Depression: a Systematic Review And Meta-analysis Of Longitudinal Studies (2013) (7)
Impact of short access nicotine self-administration on expression of α4β2* nicotinic acetylcholine receptors in non-human primates (2016) (7)
Varenicline and Bupropion for Long-Term Smoking Cessation (the MATCH Study): Protocol for a Real-World, Pragmatic, Randomized Controlled Trial (2018) (7)
Clinical management of cannabis withdrawal (2021) (6)
Dopamine receptors: structure, function and implication in psychiatric disorders (2006) (6)
Separate and combined effects of alcohol and cannabis on mood, subjective experience, cognition and psychomotor performance: A randomized trial (2022) (6)
Development and Implementation of an Ambulatory Integrated Care Pathway for Major Depressive Disorder and Alcohol Dependence. (2015) (6)
Use of candidate gene markers to guide antipsychotic dosage adjustment (2014) (6)
The effect of pre-existing alcohol use disorder on the risk of developing posttraumatic stress disorder: results from a longitudinal national representative sample (2019) (5)
Acute Effects of Cannabis on Young Drivers' Performance of Driving Related Skills (2015) (5)
fMRI (2020) (5)
Sex differences in the acute pharmacological and subjective effects of smoked cannabis combined with alcohol in young adults. (2021) (5)
Effects of therapeutic cannabis on simulated driving: A pilot study (2020) (5)
Neuropharmacology of Nicotine (2013) (5)
Novel therapeutic and drug development strategies for tobacco use disorder: endocannabinoid modulation (2020) (5)
Chapter 6 – The Role of the Endocannabinoid System in Addiction (2017) (4)
Significant association of nicotine reinforcement and cue reactivity: a translational study in humans and rats (2021) (4)
Repetitive Transcranial Magnetic Stimulation for Comorbid Major Depressive Disorder and Alcohol Use Disorder (2021) (4)
The CB1R rs2023239 receptor gene variant significantly affects the reinforcing effects of nicotine, but not cue reactivity, in human smokers (2020) (4)
Integrating a brief alcohol intervention with tobacco addiction treatment in primary care: qualitative study of health care practitioner perceptions (2019) (4)
Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review (2021) (4)
What does addiction medicine expect from neuroscience? From genes and neurons to treatment responses. (2016) (4)
Moderators for the Relationship between Post-Traumatic Stress Disorder and Opioid Use Disorder (2022) (4)
Improvement of the association between self-reported pill count and varenicline levels following exclusion of participants with misreported pill count: A commentary on Peng et al. (2017). (2018) (4)
Off-Label Use of Medications for Treatment of Benzodiazepine Use Disorder. (2015) (4)
Psychosocial and Pharmacological Interventions for the Treatment of Cannabis Use Disorder. (2019) (3)
Impact of hypertension and body mass index on quality of life in schizophrenia. (2011) (3)
Alcohol inhalation (2014) (3)
Personality: Neurobehavioural Foundation and Pharmacological Protocols (2014) (3)
Faculty of 1000 evaluation for Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers. (2018) (3)
Effects of varenicline on motor cortical plasticity in non-smokers with schizophrenia (2016) (3)
Influence of Cannabinoid Receptor 1 Genetic Variants on the Subjective Effects of Smoked Cannabis (2021) (3)
Randomized Clinical Trials Investigating Innovative Interventions for Smoking Cessation in the Last Decade. (2019) (3)
Canadian Society of Transplantation White Paper: Ethical and Legal Considerations for Alcohol and Cannabis Use in Solid Organ Listing and Allocation (2020) (3)
Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [11C]-(+)-PHNO study (2021) (3)
Survival Probabilities and Predictors of Major Depressive Episode Incidence Among Individuals With Various Types of Substance Use Disorders. (2021) (3)
Evaluating the effectiveness of bupropion and varenicline for smoking cessation using an internet-based delivery system: A pragmatic randomized controlled trial (MATCH study). (2022) (3)
Admixture analysis of Age at Onset in Schizophrenia: Genetic Association Study of 45 candidate loci (2012) (3)
Preliminary Eye-Tracking Data as a Nonintrusive Marker for Blood Δ-9-Tetrahydrocannabinol Concentration and Drugged Driving. (2021) (3)
Investigating the effects of norepinephrine α1 receptor blockade on dopamine levels: A pilot PET study with [11C]‐(+)‐PHNO in controls (2017) (3)
Posttraumatic Stress Disorder After a Psychedelic Experience, a Case Report. (2020) (3)
Pharmacotherapies for Cannabis Use Disorders: Clinical Challenges and Promising Therapeutic Agents. (2019) (3)
The impact of cannabis legalization for recreational purposes on youth: A narrative review of the Canadian experience (2022) (2)
The Human Laboratory and Drug Development in Alcohol Use Disorder: Recent Updates. (2019) (2)
Faculty of 1000 evaluation for Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. (2018) (2)
Mu opioid receptor gene variant modulates subjective response to smoked cannabis. (2022) (2)
Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial. (2022) (2)
Neuronal circuitry underlying the impact of D3 receptor ligands in drug addiction. (2015) (2)
Quantifying GABA in Addiction: A Review of Proton Magnetic Resonance Spectroscopy Studies (2022) (2)
The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics (2021) (2)
Impact Of Cyp2a6 Activity On Nicotine Reinforcement And Cue-Reactivity In Daily Smokers. (2021) (2)
Effects of combining alcohol and cannabis on driving, breath alcohol level, blood THC, cognition, and subjective effects: A narrative review. (2022) (2)
Influence of personality on acute smoked cannabis effects on simulated driving. (2021) (2)
Tobacco and Positron-Emission Tomography (PET) of the Dopaminergic System: A Review of Human Studies (2019) (2)
Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial. (2022) (2)
MR Spectroscopy of the Insula: Within- and between-Session Reproducibility of MEGA-PRESS Measurements of GABA+ and Other Metabolites (2021) (2)
Characteristics of people who report both driving after drinking and driving after cannabis use (2013) (2)
The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19 (2022) (2)
Neurochemical Alterations in Social Anxiety Disorder (SAD): A Systematic Review of Proton Magnetic Resonance Spectroscopic Studies (2022) (1)
A 35-year-old woman with low mood and concerns about her alcohol use (2017) (1)
Excitatory Amino Acids and Their Antagonists (2015) (1)
What does addiction medicine expect from neuroscience? From genes and neurons to treatment responses. (2016) (1)
Marked Increase in Amphetamine-Related Emergency Department Visits and Inpatient Admissions in Toronto, Canada, 2014–2021 (2022) (1)
Therapeutic Potential of Histamine H3 Receptors in Substance Use Disorders. (2022) (1)
Faculty Opinions recommendation of Aberrant insular cortex connectivity in abstinent alcohol-dependent rats is reversed by dopamine D3 receptor blockade. (2019) (1)
619. Brain Levels of Fatty Acid Amide Hydrolase Are Not Altered in Overweight Healthy Individuals: A Pilot PET Study with [11C]CURB (2017) (1)
The effect of nicotine dependence on the risk of developing post-traumatic stress disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). (2021) (1)
[Clinical practice guideline: medical and nonmedical therapeutic strategies for smoking cessation. Bit of therapeutic practice: management and current practice in smoking cessation]. (2003) (1)
[Carpipramine and opipramol poisoning with ventricular tachycardia]. (1985) (1)
Abnormalities of Neurotransmission in Drug Addiction (2020) (1)
Clinical Outcomes of the First 2 Years of Implementation of the Integrated Care Pathway for Concurrent Major Depressive Disorder and Alcohol Use Disorder (2017) (1)
3,4-Methylenedioxymethamphetamine (2020) (1)
Screening and Evaluation of Medications for Treating Cannabis Use Disorder (2016) (1)
Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review (2022) (1)
Association between ABCB1 rs2235048 Polymorphism and THC Pharmacokinetics and Subjective Effects following Smoked Cannabis in Young Adults (2022) (1)
S265. Endocannabinoid Metabolism and Alcohol Consumption in Youth: A PET Study With the Fatty Acid Amide Hydrolase Radioligand [11C]CURB (2018) (1)
Effects of fixed or self-titrated dosages of Sativex on cannabis users (2015) (1)
Association Study of OPRM1 Gene in a Sample of Schizophrenia Patients With Alcohol Dependence or Abuse. (2019) (1)
Deep TMS of the insula using the H-coil modulates dopamine release: a crossover [11C] PHNO-PET pilot trial in healthy humans (2017) (1)
T76. Involvement of the Endocannabinoid Enzyme Fatty Acid Amide Hydrolase in the Neurobiology of Impulsivity: Positron Emission Tomography Studies With [11C]CURB (2018) (1)
A Historical Perspective on the Dopamine D3 Receptor. (2022) (1)
The influence of conditioned stimuli on [11C]-(+)-PHNO PET binding in tobacco smokers after a one week abstinence (2021) (1)
Inhibition of monoacylglycerol lipase (MAGL) enhances cue-induced reinstatement of nicotine-seeking behavior in mice (2015) (1)
3-Year Follow-up of Lower Risk Cannabis Use Patterns: Evidence from a Longitudinal Survey (2021) (1)
Multiple Substance Use Disorders and Self-Reported Cognitive Function in U.S. Adults: Associations and Sex-Differences in a Nationally Representative Sample (2022) (1)
Personalized dosing of nicotine replacement therapy versus standard dosing for the treatment of individuals with tobacco dependence: study protocol for a randomized placebo-controlled trial (2020) (0)
P20. Measuring Endocannabinoid Metabolism During Abstinence From Alcohol in Alcohol Use DISORDER: A PET Study With the Fatty Acid Amide Hydrolase Radioligand [11C]CURB (2022) (0)
Preliminary report on the residual effects of cannabis on young drivers’ performance of driving-related skills (2015) (0)
Consensus-Based Recommendations for Titrating Cannabinoids and Tapering Opioids for Chronic Pain Control (2020) (0)
Potential Use of Opioid Antagonists in the Treatment of Marijuana Abuse and Dependence (2009) (0)
Pharmacogenetics of Lethal Opioid Overdose (2021) (0)
CHAPTER 4:The Self-medication Hypothesis in Schizophrenia: What Have We Learned from Animal Models? (2015) (0)
Dopamine D3 and D4 Receptors as Therapeutic Targets for Nicotine Addiction (2014) (0)
Physiologically-based pharmacokinetic model for predicting blood and tissue tetrahydrocannabinol concentrations (2021) (0)
Faculty of 1000 evaluation for Adverse health effects of marijuana use. (2018) (0)
Faculty of 1000 evaluation for A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. (2018) (0)
Studying the Role of D4 Receptors in Psychiatric Illnesses and Related Functions With L-745,870 (2018) (0)
Studying the Role of D4 Receptors in Psychiatric Illnesses and Related Functions With L-745,870 (2018) (0)
Faculty of 1000 evaluation for Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis. (2018) (0)
Alcohol Related Harm: An Introduction to the Special Issue (2020) (0)
Impairment of Neuroplasticity in the Dorsolateral Prefrontal Cortex by Alcohol (2017) (0)
No previous studies have examined collision risk among people who self-report both DUIA and DUIC. The current data suggest that those who report both behaviours could be at a particularly high risk for collision. (2014) (0)
Cannabinoid Drugs in Mental Health Disorders (2021) (0)
Effects of Nicotine in Animal Models of Drug Addiction Across Species (2013) (0)
Muscarinic Cholinergic Receptor Agonists and Antagonists (2015) (0)
P.1.006 Molecular basis of alcohol intake: role of D3 dopaminergic receptor (2014) (0)
Faculty Opinions recommendation of Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. (2018) (0)
Medical cannabis in mental health–substance use (2017) (0)
S.27.05 Nicotine and dopamine D3 receptor: Implications in drug addiction and Parkinson's disease (2003) (0)
S203. Fatty Acid Amide Hydrolase Polymorphism C385A Associated With Dopamine D2/3 Receptor Levels: A PET Study With [11C]-(+)-PHNO (2019) (0)
Circadian alteration in neurobiology during protracted opiate withdrawal (2010) (0)
Targeting the Dopamine D 3 Receptor for Treatment of Nicotine Dependence (2006) (0)
Investigating Fatty Acid Amide Hydrolase Levels in Social Anxiety Disorder: A Positron Emission Tomography (PET) Study Using [C-11]CURB (2020) (0)
475. Measuring Endocannabinoid Metabolism in Alcohol Use Disorder: a PET Study With the Fatty Acid Amide Hydrolase Radioligand [11C]CURB (2023) (0)
386. Fatty Acid Amide Hydrolase is Associated With Impulsiveness: A Pet Study in Overnight Abstinent Chronic Cannabis Users (2023) (0)
Pharmacological Treatment of Alcohol Use Disorder (2020) (0)
346. Endocannabinoid Metabolism Linked With Alcohol Use in Individuals With Social Anxiety Disorder: A Positron Emission Tomography Study With [11C]CURB (2023) (0)
Faculty of 1000 evaluation for Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial. (2018) (0)
UvA-DARE (Digital Academic Repository) A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction an international Delphi consensus study (2019) (0)
Treatment of Nicotine Dependence: Toward a Partial Solution (2006) (0)
FOR A ROLE OF SYNERGISTIC D 1 Receptor Heteromers : INDICATIONS 3 D − 1 Identification of Dopamine D Mechanisms of Signal Transduction : (2008) (0)
Faculty of 1000 evaluation for A systematic review of the respiratory effects of inhalational marijuana. (2018) (0)
Assessment and management of substance use during rTMS treatment for psychiatric disorders: Development of a delphi-method-based expert consensus guideline (2023) (0)
The Rat Gambling Task as a model for the preclinical development of treatments for gambling disorder (2018) (0)
P.3.c.031 Treatment resistant schizophrenia: analysis of polymorphic CpG sites in 40 annotated genes (2011) (0)
Faculty of 1000 evaluation for Cannabidiol as a potential new type of an antipsychotic. A critical review of the evidence. (2018) (0)
Investigating Brain Monoamine Oxidase B Status in Alcohol Use Disorder With the Positron Emission Tomography (PET) Tracer [C-11]SL25.1188 (2020) (0)
Inverse relationship between basal expression of α4β2⁎ nicotinic acetylcholine receptors and motivation to self-administer nicotine in non-human primates (2008) (0)
Quantification of α4β2* nicotinic acetylcholine receptors (nAChRs) in squirrel monkey brain using PET and 2FA (2006) (0)
Comparing immediate- and delayed-onset posttraumatic stress disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III). (2022) (0)
Faculty Opinions recommendation of Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial. (2019) (0)
Faculty Opinions recommendation of A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy. (2019) (0)
The COVID-19 impact and characterization on substance use-related emergency department visit for adolescents and young adults in Canada: Practical implications. (2023) (0)
Differential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on nicotine versus cocaine self-administration and relapse in squirrel monkeys (2015) (0)
Differential effect of cannabis use on opioid agonist treatment outcomes: Exploratory analyses from the OPTIMA study. (2023) (0)
Faculty Opinions recommendation of Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double-blind randomized controlled trial. (2021) (0)
Medical Cannabis and Past-Year Cannabis Use Disorder Among Adult Recreational Users in the United States: Results From a Nationally Representative Sample (2022) (0)
Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial. (2022) (0)
Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adults (2019) (0)
Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats (2016) (0)
The Rat Gambling Task as a model for the preclinical development of treatments for gambling disorder (2018) (0)
Imaging Histamine H3 Receptors with Positron Emission Tomography. (2021) (0)
Melatonin for Treatment-Seeking Alcohol Use Disorder patients with sleeping problems: A randomized clinical pilot trial (2020) (0)
Effects of disulfiram on choice behavior in a rodent gambling task: association with catecholamine levels (2017) (0)
Desvenlafaxine (2018) (0)
Faculty Opinions recommendation of A large-scale genome-wide association study meta-analysis of cannabis use disorder. (2020) (0)
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial (2022) (0)
Epival (1997) (0)
The Utility of THC Cutoff Levels in Blood and Saliva for Detection of Impaired Driving. (2023) (0)
Nicotine Self-Administration as Paradigm for Medication Discovery for Smoking Cessation: Recent Findings in Medications Targeting the Cholinergic System. (2019) (0)
Cannabinoid Therapy: Attitudes and Experiences of People With Chronic Pain. (2023) (0)
SNP (2020) (0)
Predictive Validity (2022) (0)
Faculty Opinions recommendation of Nabiximols for the treatment of cannabis dependence: A randomized clinical trial. (2019) (0)
Exploring the role of the Ser9Gly (rs6280) Dopamine D3 receptor polymorphism in nicotine reinforcement and cue-elicited craving (2020) (0)
Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review (2022) (0)
Cost-effectiveness of flexible take-home buprenorphine-naloxone versus methadone for treatment of prescription-type opioid use disorder. (2023) (0)
Faculty Opinions recommendation of 5HT-2C agonist lorcaserin decreases cannabis self-administration in daily cannabis smokers. (2021) (0)
Monitoring the impact of cannabis use (2022) (0)
Alcohol Impairs N100 Response to Dorsolateral Prefrontal Cortex Stimulation (2018) (0)
Faculty Opinions recommendation of Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework. (2020) (0)
Sensitivity to change of generic preference-based instruments (EQ-5D-3L, EQ-5D-5L, and HUI3) in the context of treatment for people with prescription-type opioid use disorder in Canada (2023) (0)
Faculty Opinions recommendation of Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. (2018) (0)
Encoding (2021) (0)
Evaluating Back-to-Back and Day-to-Day Reproducibility of Cortical GABA+ Measurements Using Proton Magnetic Resonance Spectroscopy (1H MRS) (2023) (0)
A case of diagnosing a long-standing psychotic disorder during medical withdrawal. (2012) (0)
[Future medications for tobacco and cannabis dependence]. (2008) (0)
Faculty Opinions recommendation of Ventral pallidum DRD3 potentiates a pallido-habenular circuit driving accumbal dopamine release and cocaine seeking. (2021) (0)
Effectiveness of bupropion and varenicline for smokers with baseline depressive symptoms. (2022) (0)
Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies (2018) (0)
Efficacy (2021) (0)
Correction: Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review (2022) (0)
The agranular and granular insula differentially contribute to gambling-like behavior on a rat slot machine task: effects of inactivation and local infusion of a dopamine D4 agonist on reward expectancy (2016) (0)
The Role of Dopamine D3 Receptors in Tobacco Use Disorder: A Synthesis of the Preclinical and Clinical Literature. (2022) (0)
Faculty Opinions recommendation of Cannabis use and risk of prescription opioid use disorder in the united states. (2020) (0)
The Impact of religiosity/spirituality on slowing the progression of substance use: Based on the National Epidemiological Survey of Alcohol and Related Conditions (NESARC-III). (2023) (0)
Faculty Opinions recommendation of Randomized Trial of Reduced-Nicotine Standards for Cigarettes. (2020) (0)
The 43rd Annual Meeting of the Canadian College of Neuropsychopharmacology, November 4, 2021 (2022) (0)
Insula deep rTMS and varenicline for smoking cessation: A randomized control trial study protocol (2022) (0)
Contributors (2019) (0)
Research Participation in Substance Use Disorder Trials: Design and Methods of a Multi-Site Nested Qualitative Study (2022) (0)
Association between Fatty Acid Amide Hydrolase and Alcohol Response Phenotypes: A PET Imaging Study with [11C]CURB in Heavy-drinking Youth (2022) (0)
Faculty Opinions recommendation of Deconstructing the neurobiology of cannabis use disorder. (2020) (0)
Repetitive Behavior (2021) (0)
The effects of buspirone on occupancy of dopamine receptors and the rat gambling task (2017) (0)
Separated (2020) (0)
Impact of short access nicotine self-administration on expression of α4β2* nicotinic acetylcholine receptors in non-human primates (2016) (0)
Impacts of recreational cannabis legalization on use and harms: A narrative review of sex/gender differences (2023) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Bernard Le Foll?

Bernard Le Foll is affiliated with the following schools:

Université Paris Cité
University of Toronto